Portfolio company
CNSDose
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides genetic testing kits to help healthcare providers and patients select antidepressants and other medications based on individual cheek swab results.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genomind
The company develops pharmacogenetic tests and decision support software to help healthcare providers and patients personalise medication selection based on individual genetic profiles.
OneOme
This company provides pharmacogenomic testing and clinical software to help healthcare organisations and providers tailor medication decisions to a patient's genetic profile.
Prairie Health
This company provides telepsychiatry and genetic testing to help individuals suffering from anxiety and depression find appropriate medication.
Cytox
This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.
23andMe
The company provides direct-to-consumer genetic testing kits and health reports to individuals for ancestry discovery and health risk assessment.
Adyn
This company provides at-home biological testing and telemedicine services to help patients select hormonal birth control based on their genetic risk and hormone levels.
ADNtro
This company provides home saliva kits and genetic analysis to give individuals insights into their ancestry, health, nutrition, and fitness predispositions.
CardioDx
This company produces a genomic blood test for clinicians to assess the likelihood of obstructive coronary artery disease in symptomatic, non-diabetic patients.
